ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,681Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 20

$575K Total Retail Price of All Prescriptions

Rank: 1 out of 20

357 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 357 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

42% of this provider’s 357 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,123 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 934 493 S3 1 1
LISINOPRIL 412 261 2 3
OMEPRAZOLE 372 249 3 4
FUROSEMIDE 349 237 4 7
METOPROLOL TARTRATE 335 247 5 8
SIMVASTATIN 291 206 6 2
AMLODIPINE BESYLATE 270 192 7 6
LEVOTHYROXINE SODIUM 257 179 8 5
WARFARIN SODIUM 216 171 9 12
METFORMIN HCL 209 107 10 9
HYDROCHLOROTHIAZIDE 178 122 11 10
CITALOPRAM HBR 142 109 12 27
LOVASTATIN 141 96 13 19
LOSARTAN POTASSIUM 139 119 14 15
SERTRALINE HCL 123 39 15 23
ADVAIR DISKUS 123 83 15 29
ISOSORBIDE MONONITRATE ER 121 102 17 38
CARVEDILOL 118 87 18 18
ALBUTEROL SULFATE 114 81 19 42
LANTUS 106 62 20 54
GLIPIZIDE 106 74 20 43
PROAIR HFA 106 66 20 54
GABAPENTIN 105 39 23 14
ZOLPIDEM TARTRATE 105 67 23 20
KLOR-CON 10 104 79 25 56
CLONIDINE HCL 103 45 26 58
CLOPIDOGREL 97 68 27 34
KLOR-CON M20 94 52 28 44
MIRTAZAPINE 90 89 29 45
TAMSULOSIN HCL 87 50 30 22
HYDRALAZINE HCL 85 66 31 40
LEVETIRACETAM 85 30 31 61
DONEPEZIL HCL 84 66 33 35
RANITIDINE HCL 82 56 34 30
METOPROLOL SUCCINATE 81 67 35 11
RISPERIDONE 81 69 35 63
POTASSIUM CHLORIDE 81 55 35 25
SPIRIVA 80 57 38 30
PREDNISONE 76 60 39 48
KLOR-CON M10 75 68 40 64
TRIAMTERENE-HCTZ 74 47 41 52
FLUTICASONE PROPIONATE 74 24 41 28
PLAVIX 73 55 43 65
FENTANYL 72 22 S2 44 66
IPRATROPIUM BROMIDE 70 40 45 67
INSULIN SYRINGE 64 34 46 72
AZITHROMYCIN 62 49 47 33
PAROXETINE HCL 61 43 48 77
PANTOPRAZOLE SODIUM 59 36 49 49
ATORVASTATIN CALCIUM 57 43 50 16
LANTUS SOLOSTAR 57 17 50 53
DIGOXIN 56 48 52 79
DILTIAZEM 24HR CD 56 52 52 79
LYRICA 53 22 54 84
PRAVASTATIN SODIUM 53 49 54 17
TRAZODONE HCL 52 46 56 85
DIOVAN 51 50 57 38
PHENYTOIN SODIUM EXTENDED 50 35 58 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.